Latest Hisamitsu Pharmaceutical Stories
New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle can also treat moderate to severe hot flashes due to menopause MIAMI and
Minivelle now approved for prevention of postmenopausal osteoporosis at all doses MIAMI and NEW YORK, Sept. 24, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc.
ReportsnReports.com adds “Transdermal Drug Delivery Market & Clinical Pipeline Insight” report to its research database. Dallas, Texas (PRWEB) May 04,
DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sjg3pf/hormone) has announced the addition of the "Concise Analysis
Reportbuyer.com just published a new market research report:
TORRANCE, Calif., May 24 /PRNewswire/ -- Hisamitsu, a world leader in the manufacture of external pain relieving drugs, announced the release of two products for the American market--SALONPASÂ® PAIN RELIEF PATCH and ARTHRITIS PAIN.